Myriad Genetics, Inc.— Sankey Diagram

Annual mode · period ending 2025-12-31 · SEC EDGAR

FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$707M
↓-31.2% -$321Mvs FY2024
Total Liabilities
$339M
↑+3.7% +$12Mvs FY2024
Equity
$368M
↓-47.5% -$333Mvs FY2024
Cash
$150M
↑+46.1% +$47Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
Reconciled values per the annual mode pipeline. Compare against SEC EDGAR filings.
Line itemFY2025FY2024
Total Assets$707M$1.03B
Current Assets$333M$298M
Cash$150M$102M
ST Investments$0$0
Receivables$115M$121M
Inventory$31M$28M
Other Current$37M$47M
Non-Current Assets$374M$730M
PPE$114M$117M
Goodwill$52M$286M
Intangibles$153M$262M
Investments$0$0
Other Non-Current$55M$64M
Total Liab+Eq$707M$1.03B
Current Liab.$134M$164M
Accounts Payable$30M$32M
Short-Term Debt$0$0
Deferred Revenue$0$0
Other CL$104M$132M
Non-Current Liab.$205M$162M
Long-Term Debt$120M$40M
Other LT Liab.$85M$123M
Equity$368M$701M
Retained Earnings$1.12B$757M
Other Equity$0$0

QuarterCharts · SEC EDGAR data · MYGN · Comparing FY2025 vs FY2024